Professional orientation and Image-building activities

Effective development of the pharmaceutical industry and European integration processes in the field of education in general involves new approaches to the training of pharmaceutical personnel in higher education institutions.

In order to fulfill these tasks it is appropriate to examine issues concerning scientific and methodological work and organization of educational process of the specialists in the field of pharmacy, exchange of experience on scientific cooperation with the relevant foreign higher education institutions.

During the year the NUPh delegations visited a number of CIS countries, African and the Middle East countries in order to carry out active vocational guidance to attract foreign students. Presentations of the University were held in profession-oriented secondary schools, in universities-partner; there were organized meetings on the level of the Ministries of Health, Ministries of Higher Education and Embassies. Large-scale vocational guidance work was conducted to increase the number of international students first of all from the CIS countries next year and included master class lectures by the NUPh professors.

From May 18 to May 26, 2018, delegation of the National University ща Pharmacy visited the Medical University of Warsaw

The NUPh delegation consisting of Head of the Department of Pharmacognosy Professor Koshovyi Oleh Mykolaiovych, Professor of the Department of Pharmacognosy Ilina Tetiana Vasylivna and Associate Professor of the Department of Pharmacotherapy Zhabotynska Nataliia Volodymyrivna with a group of students: Alieksieichuk Kateryna V., Hrytsai Nadiia F., Kapelka Ihor H., Kravchuk Yuliia V., Kryvolapova Anna A., Myha Mykhail M. and Vlasova Inna K. visited the Medical University of Warsaw (Poland, Warsaw) from May 18, 2018 to May 26, 2018.

During the visit, Professor Koshovyi O. M., Professor Ilina T.V. and Associate Professor Zhabotynska N.V. underwent a pedagogical internship on the basis of the Warsaw Medical University and headed the group of students during the practical training in Pharmacognosy and introductory medical practical training in the framework of the inter-university agreement between the National University of Pharmacy and the Medical University of Warsaw. Postgraduate student of the Department of Pharmacognosy Myha M. M. had an internship on the basis of the Department of Pharmacognosy, where he performed a part of his scientific dissertation.

During the visit, the NUPh delegation had a series of meetings, training and educative activities: meeting with staff of the International Department of the Medical University of Warsaw, visit to the Department of Pharmacognosy (where each student personally mastered several methods of pharmacognostical analysis), Department of Otolaryngology (presence during the tumor removal surgery) and the Stimulation Center.

The delegation visited the Warsaw Botanical Garden, the Royal Lazenki Park, the Warsaw Zoo, the Planetarium, the Copernicus Science Center and the Fryderyk Chopin Museum. The delegation had an excursion to the historic center of Warsaw, the residence of the king-warrior Jan III Sobieski and the Royal Park in Vilyanov.

Thus, the organization of the educational process at the Medical University of Warsaw was studied in order to introduce European experience in the NUPh; the faculty members got acquainted with problems of the educational process in medical and pharmaceutical higher education establishments in conditions of new educational and information technologies and integration into the scientific space.


On May 7-9, 2018, employees of the Department of Pharmacotherapy, Associate Professor Trishchuk N.M. and Junior Research Associate Botsula I.V., had a foreign business trip to the Czech Republic in order to participate in the International Conference “CREDENCE Summit Meeting” at the invitation of Janssen and IQVIA.

180 participants from different countries of Europe, Asia and Australia took part in the Conference. The Conference was devoted to the clinical research “Randomized, double-blind, event-driven, placebo-controlled, multicenter study of the cannaroglofosin effect on renal and cardiovascular systems outcomes in patients with type 2 diabetes mellitus and diabetic nephropathy,” the study code 28431754DNE3001.

The trip resulted in scientifically substantiated answers obtained to the following questions: current research data on the group of sugar-lowering drugs (SGLT2), namely, cannagliflozin; peculiarities of the study 28431754DNE3001, intermediate results of the study are presented, questions of the protocol updates (INT5-INT6), review of the updated system for electronic patient registration and difficulties in completing the SRF, deadlines for completing reports on suspicion of an undesirable reaction to the study drug.

The reports were delivered by: Steering Committee Chairman (Vlado Perckovic), Robert Edwards and Alan Jenkins (Janssen), Renata Yong (George Clinical), EMEA Scientific Lead (Hiddo L. Heerspink), Joedy Lister (IQVIA) Hiddo L. Heerspink), Joedy Lister (IQVIA).

The NUPh delegation also took part in master classes on the following topics:

– reporting on a study endpoints;

– search for the best practices;

– skills of analysis and management of patients after identification of the reasons for their refusal in further monitoring and participation.

Methods to identify the main problems, which researchers have in the 3rd year of the study, were developed; the participants shared their experience (different countries and hospitals).


On April 22 – 26, 2018, delegation of the Department of Clinical Pharmacology and Clinical Pharmacy of the National University of Pharmacy, consisting of: Prof. Zupanets I.A. Assoc. Prof. Zupanets K.O., Assoc. Prof. Shebeko S.K. and the Assistant Zhulai T.S. participated in the 27th Congress of the European Rhinologic Society / ERS 2018 27th Congress of the European Rhinologic Society, which was devoted to the problems of diagnosis, endoscopic treatment of acute and chronic polypous rhinosinusitis, London (UK).

More than 1800 delegates from more than 60 countries of the world took part in the Congress, including 33 delegates from Ukraine. Issues of preclinical studies in otolaryngology, in particular in rhinology, were considered during the Congress.

Within the framework of the scientific part of the Congress, the NUPh delegation presented the oral report entitled “Experimental study of the effect of Sinupret on the course of leukotriene-dependent inflammation as a drug for pathogenetic therapy of rhinosinusitis” (authors: Prof. Zupanets I.A., Assoc. Prof. Zupanets K.O., Assoc. Prof. Shebeko S.K., spokesperson: Assoc. Prof. Zupanets K.O.) and poster report “Perspectives for use of the new nasal spray with anti-inflammatory action in treatment of acute rhinosinusitis” (authors: Zhulai T.S., Shebeko S.K., NUPh in co-authorship with Hoi A.M., JSC “Farmak”, spokespersons: Zhulai T.S., Shebeko S.K.) and took part in various scientific events: round tables, master classes, symposiums, debates, etc.

As a result, new knowledge in the field of rhinology was acquired; scientific cooperation on preclinical and clinical research in this area was broadened. The collection of abstracts, including reports of the NUPh representatives, was published.

Participants received Certificates, which are equal to 30 credits in accordance with CME / CPD Accreditation.

On March 26-30, 2018, Head of the Department of Physical and Colloid Chemistry of the National University of Pharmacy Prof. Kabachnyi V.I. had a business trip to the Republic of Lithuania under the contract of 24.11.2017 between the National University of Pharmacy and the Agricultural Chamber of the Republic of Lithuania.

Purpose of the trip is to participate in the experimental research of technology using the ecologically-friendly crop activators proposed by the NUPh, and to establish scientific cooperation between the NUPh and the interested institutions of the Republic of Lithuania in the field of innovative scientific research (various environmentally safe biotechnologies).

As a result of the trip, contacts were established with scientists and producers of agrobiological products, areas for possible cooperation were discussed and the cooperation agreement was signed.

On March 12-13, 2018, Head of the Department of Pharmacotherapy Prof. Kireiev Ihor Volodymyrovych participated in the international scientific and practical conference “PRO2TEST” at the invitation of Akebia Therapeutics Inc. (Prague, Czech Republic).

During the conference, the issues of pharmacokinetics and pharmacodynamics of dapepoetin and adadastat, effectiveness and safety of their therapeutic use were considered; schemes of pharmacotherapy during chronic kidney disease for the correction of anemia, in comorbid conditions; use of the HemoCue apparatus for rapid detection of hemoglobin levels in order to further adjust its amount, depending on the transmitted coronary and thromboembolic events.

During the visit to the Czech Republic an agreement was concluded with the NUPh on educational, methodological and scientific cooperation for the purpose of coordination with the leadership of the Pharmaceutical Faculty of the Charles University, Hradec Karlov. A visit to the Czech Republic of the NUPh delegation is planned in the nearest future with a view to discussing joint participation in projects of the Erasmus + grant program.

On February 16-25, 2018, delegation of the National University of Pharmacy made a business trip to the Kingdom of Belgium to participate in the International Conference ChemCYS 2018 at the invitation of the Flemish Young Scientists’ Organization “Jong-KVCV”.

The NUPh delegation consisted of: staff of the Department of Pharmaceutical Chemistry: Head of the Department, Professor Georgiyants Viktoriia Akopivna, Associate Professor Bevz Nataliia Yuriivna, Associate Professor Harna Nataliia Vasylivna, postgraduate student Bezruk Ivan Volodymyrovych, postgraduate student Dobrova Anna Olehivna; staff of the Department of Quality, Standardization and Certification of Drugs of the Institute for Pharmacy Professionals’ Qualification I,provement of the NUPh: Head of the Department, Professor Harna Svitlana Vasylivna, Associate Professor Mishchenko Volodymyr Anatoliiovych, Assistant Anna Materiienko; Head of the State scientific-research laboratory of the NUPh for medicinal substances quality control Hubar Svitlana Mukolaiivna.

Visits to the faculties of pharmaceutical sciences at the Universities of Ghent and Antwerp were conducted during the trip.

During the visit, the NUPh delegation had a meeting with the Head of the Department of Medical Chemistry, Professor Koen Augustyns and discussed the ways of possible cooperation.

This was a great opportunity to get acquainted with the peculiarities of pharmaceutical education in Belgium: future pharmacists begin their training with a bachelor of pharmacy. During this training program, a student receives general and scientific competences, as well as basic knowledge of basic medicines (“pharmaceutical knowledge”) and diseases (“medical basic knowledge”). After the Bachelor’s  Degree, pharmacists can continue their education through two primary Master’s Programs. In the Master’s Programs in pharmaceutical care, emphasis is placed on the relationship between a patient-pharmacist, a patient physician and a patient-care provider. This program is primarily prepares for work in a pharmacy or in a hospital, possibly after qualification improvement program “Master-after-Master” in a hospital pharmacy. It can also lead to the career of a researcher, work with the government, and so on. The Master in Drug Development focuses on a medicine itself, rather than on a patient-oriented context. Students who are more focused on the industry tend to choose the direction of their Master’s Degree in drug development, often with a postgraduate program “Master-after-Master” in industrial pharmacy.

On February 21-23, the delegation took part in the conference ChemCYS 2018 in Blankenberge.

On the first day they attended a lecture by Nobel Prize laureate in chemistry, Doctor of Sciences, Professor Bernard Feringa on the topic: “The Art of Building Small.”

Posters of the Assistant of the Department of Quality and Standardization of IPhPQI Anna Materiienko Sergiivna on the topic “Development of control methods for studying pollutions of pharmaceutical production in wastewater” and Associate Professor of the Department of Quality and Standardization of IPhPQI Mishchenko Volodymyr Anatoliiovych on the topic “Anticonvulsant activity of herbal substances”.

On the second day of the conference, there was a lecture by Doctor of Science, Professor of Chemistry at the University of Nottingham Sir Martin Polakoff “Towards Greener Photochemistry.”

On the same day, postgraduate students of the Pharmaceutical Chemistry Department Bezruk Ivan Volodymyrovych and Dobrova Anna Olehivna presented oral presentations on the topics: “Using the HPLC Method for Quantitative Determination of Active Pharmaceutical Ingredients in the Process of Industrial Synthesis” and “Study of Doxycycline Interaction with Some Mineral Waters and Drinks” respectively. In addition, their papers were presented by Professor Harna Svitlana Vasylivna and Professor Georgyants Viktoriia Akopivna, Associate Professor Harna Nataliia Vasylivna, Bevz Nataliia Yuriivna, Hubar Svitlana Mykoliivna.

On the final day of the conference, master classes and seminars were attended, as well as a lecture by Doctor of Sciences, Professor Joe van Hinderhochter “Becoming an Immune Against Cancer: Development of Anti-Cancer Vaccines.”

On February 11 – 28, 2018, at the invitation of the Lithuanian Pharmaceutical Association, the Dean of the qualification improvement department of the Institute of Pharmacy Professionals Qualification Improvement of the National University of Pharmacy, Candidate of Pharmaceutical Sciences, Associate Professor Velykyi Dmytro Lvovych visited the Lithuanian University of Health Sciences (Kaunas, Lithuania).The purpose of this business trip: acquaintance with the postgraduate education experience of the pharmaceutical industry specialists accumulated by the Lithuanian University of Health Sciences, with the experience of professional associations of the Republic of Lithuania (Vilnius).

In the course of his business trip, Assoc. Prof. Velykyi D.L. familiarized himself with the legal framework that regulates the continuous professional development of pharmacy specialists of the Republic of Lithuania, and its practical implementation.

The Republic of Lithuania has a three-stage pharmaceutical education: pre- and postgraduate pharmaceutical education (advanced training) and continuous professional development.

Postgraduate pharmaceutical education lasts from 1 to 10 years. The requirements for it are outlined in the national standards of higher pharmaceutical education. Responsibility for training is assigned to higher education institutions, Ministry of Health, professional associations.

Continuous professional development lasts for 30-40 years, that is, during the whole work activity of a specialist. Responsibility is assigned personally to the pharmacist, the Lithuanian Pharmaceutical Association, the Ministry of Health, and others.

The role of various organizations in the continuous professional development of pharmacists:

  1. Healthcare authorities (seminars, on-the-job training, companies).
  2. Higher education institutions (new technologies, lectures, seminars).
  3. Lithuanian Association of Pharmacists, international programs (congresses, conferences, internships abroad).

The right to choose the form of continuing professional education remains directly with the pharmacist.

The confirmation of professional competence is expressed through the credit system. Appropriate scales are used to assess the scope and the quality of professional competence. In the absence of the necessary number of credits within 5 years, the professional competence is confirmed in the profile commissions (administration and LFA).

Failure of the specialist to meet the state’s requirements for his/her own continuous professional development can lead to the withdrawal of a certificate (license) for pharmaceutical activi